Hausdorff J M, Schaafsma J D, Balash Y, Bartels A L, Gurevich T, Giladi N
Movement Disorders Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Sackler School of Medicine, Tel-Aviv University, 6 Weizmann Street, 64239 Tel Aviv, Israel.
Exp Brain Res. 2003 Mar;149(2):187-94. doi: 10.1007/s00221-002-1354-8. Epub 2003 Jan 22.
Patients with Parkinson's disease (PD) often experience freezing of gait, a debilitating phenomenon during which the subject suddenly becomes unable to start walking or to continue to move forward. Little is known about the gait of those subjects with PD who experience freezing of gait or the pathophysiology of freezing. One possibility is that freezing of gait is a truly paroxysmal phenomenon and that the usual walking pattern of subjects who experience freezing of gait is not different than that of other patients with PD who do not experience these transient episodes of freezing of gait. On the other hand, a recent study noted gait changes just prior to freezing and concluded that dyscontrol of the cadence of walking contributes to freezing. To address this question, we compared the gait of PD subjects with freezing of gait to PD subjects without freezing of gait. Given the potential importance of the dyscontrol of the cadence of walking in freezing, we focused on two aspects of gait dynamics: the average stride time (the inverse of cadence, a measure of the walking pace or rate) and the variability of the stride time (a measure of "dyscontrol," arrhythmicity and unsteadiness). We found that although the average stride time was similar in subjects with and without freezing, stride-to-stride variability was markedly increased among PD subjects with freezing of gait compared to those without freezing of gait, both while "on" (P<0.020) and "off" (P<0.002) anti-parkinsonian medications. Further, we found that increased gait variability was not related to other measures of motor control (while off medications) and levodopa apparently reduced gait variability, both in subjects with and without freezing. These results suggest that a paradigm shift should take place in our view of freezing of gait. PD subjects with freezing of gait have a continuous gait disturbance: the ability to regulate the stride-to-stride variations in gait timing and maintain a stable walking rhythm is markedly impaired in subjects with freezing of gait. In addition, these findings suggest that the inability to control cadence might play an important role in this debilitating phenomenon and highlight the key role of dopamine-mediated pathways in the stride-to-stride regulation of walking.
帕金森病(PD)患者常经历步态冻结,这是一种使人衰弱的现象,在此期间患者会突然无法开始行走或继续向前移动。对于那些经历步态冻结的PD患者的步态以及步态冻结的病理生理学,我们知之甚少。一种可能性是,步态冻结是一种真正的阵发性现象,经历步态冻结的患者的正常行走模式与未经历这些短暂步态冻结发作的其他PD患者并无不同。另一方面,最近一项研究注意到在步态冻结之前的步态变化,并得出结论认为步行节奏的失调导致了步态冻结。为了解决这个问题,我们将有步态冻结的PD患者的步态与没有步态冻结的PD患者的步态进行了比较。鉴于步行节奏失调在步态冻结中可能具有的重要性,我们重点关注了步态动力学的两个方面:平均步幅时间(节奏的倒数,衡量步行速度或速率)和步幅时间的变异性(衡量“失调”、无节律性和不稳定性)。我们发现,尽管有步态冻结和没有步态冻结的患者平均步幅时间相似,但与没有步态冻结的患者相比,有步态冻结的PD患者在服用抗帕金森病药物“开”期(P<0.020)和“关”期(P<0.002)时,步幅间变异性均显著增加。此外,我们发现步态变异性增加与其他运动控制指标(在未服用药物时)无关,左旋多巴显然降低了有和没有步态冻结的患者的步态变异性。这些结果表明,我们对步态冻结的看法应该发生范式转变。有步态冻结的PD患者存在持续的步态障碍:在有步态冻结的患者中,调节步态时间步幅间变化并维持稳定步行节奏的能力明显受损。此外,这些发现表明,无法控制节奏可能在这种使人衰弱的现象中起重要作用,并突出了多巴胺介导的通路在步行步幅间调节中的关键作用。